title: [Update on current care guideline: atrial fibrillation].
abstract: The prevalence and incidence of atrial fibrillation (AF) are increasing rapidly. Key recommendations in management of AF include prompt administration of oral anticoagulation to all patients with elevated risk of thromboembolic complications, proper use of antiarrhythmic drugs and invasive therapies in highly symptomatic patients and adequate rate control in patients with permanent AF. The selection between warfarin and the novel oral anticoagulants (apixaban, dabigatran, rivaroxaban) is based on careful evaluation of the benefits and disadvantages of the drugs in a given patient.
authors.forename: Pekka
authors.initials: P
authors.lastname: Raatikainen
authors.forename: Kari
authors.initials: K
authors.lastname: Askonen
authors.forename: Matti
authors.initials: M
authors.lastname: Halinen
authors.forename: Heikki
authors.initials: H
authors.lastname: Huikuri
authors.forename: Juhani
authors.initials: J
authors.lastname: Koistinen
authors.forename: Hannu
authors.initials: H
authors.lastname: Parikka
authors.forename: Marja
authors.initials: M
authors.lastname: Puurunen
authors.forename: Vesa
authors.initials: V
authors.lastname: Virtanen
mesh_terms: D000284:Administration, Oral; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D006801:Humans; D015994:Incidence; D009025:Morpholines / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D015995:Prevalence; D011720:Pyrazoles / Q000627:therapeutic use; D011728:Pyridones / Q000627:therapeutic use; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D000991:Antithrombins; D001562:Benzimidazoles; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran